Related Experiment Video
Updated: Jan 13, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
DCGAT-DTI: dynamic cross-graph attention network for drug-target interaction prediction
Abrar Rahman Abir1, Muhtasim Noor Alif2, Wencai Zhang3
1Department of Computer Science and Engineering, Bangladesh University of Engineering and Technology, Dhaka 1000, Bangladesh.
Motivation:
Drug-target interaction (DTI) prediction accelerates drug discovery by identifying interactions between chemical compounds and proteins. Existing methods often rely on drug-drug and protein-protein similarity graphs but process them independently, limiting their ability to model interdependencies between modalities. Moving beyond isolated embedding generation from protein and drug graphs, we propose DCGAT-DTI, a novel deep learning framework with a dynamic cross-graph attention (DCGAT) module that dynamically models intra- and cross-graph interactions. Initial embeddings are generated using pretrained language models. Similarity graphs constructed from these embeddings are passed to DCGAT, which uses a Graph Convolutional Network-based Cross-Neighborhood Selection network to dynamically select cross-modal neighbors. This allows drug and protein embeddings to incorporate information from both modalities through intra- and cross-graph attention mechanisms.
Results:
Extensive evaluations on four benchmark datasets demonstrate that DCGAT-DTI outperforms state-of-the-art methods across warm and cold start splits for both balanced and unbalanced datasets. In the challenging unbalanced cold start scenarios, it achieves significant improvement in performance for both drugs and proteins over the baselines.
Availability And Implementation:
Source code is available at https://github.com/compbiolabucf/DCGAT-DTI.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Related Concept Videos
Protein-protein Interfaces
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Pharmacokinetics: Drug–Drug Interactions